High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ccop - Scottsdale Oncology Program
Scottsdale, Arizona, United States
- Sylvester Cancer Center, University of Miami
Miami, Florida, United States
- H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
- Ccop - Evanston
Evanston, Illinois, United States
- Ccop - Illinois Oncology Research Association
Peoria, Illinois, United States
- Indiana University Cancer Center
Indianapolis, Indiana, United States
- Veterans Affairs Medical Center - Indianapolis (roudebush)
Indianapolis, Indiana, United States
- New England Medical Center Hospital
Boston, Massachusetts, United States
- Mayo Clinic Cancer Center
Rochester, Minnesota, United States
- Ccop - Metro-Minnesota
Saint Louis Park, Minnesota, United States
- University of Rochester Cancer Center
Rochester, New York, United States
- Ireland Cancer Center
Cleveland, Ohio, United States
- Vanderbilt Cancer Center
Nashville, Tennessee, United States
- Veterans Affairs Medical Center - Nashville
Nashville, Tennessee, United States
- Ccop - Marshfield Medical Research and Education Foundation
Marshfield, Wisconsin, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
- Veterans Affairs Medical Center - Milwaukee (zablocki)
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 16 Nov 1998
- Primary completion
- 31 Dec 2002
- Completion
- —
- Last update posted
- 22 Jun 2023
- Registered enrollment
- —
- Registry id
- NCT00003353
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.